Literature DB >> 16235388

Surgery for traumatic optic neuropathy.

P Yu-Wai-Man1, P G Griffiths.   

Abstract

BACKGROUND: Traumatic optic neuropathy (TON) is an important cause of severe visual loss following blunt or penetrating head trauma. Following the initial insult optic nerve swelling within the optic nerve canal or compression by bone fragments are thought to result in secondary retinal ganglion cell loss. Optic nerve decompression with steroids or surgical interventions or both have therefore been advocated to improve visual prognosis in TON.
OBJECTIVES: The aim of this review was to examine the effects and safety of surgical interventions in the management of TON. SEARCH STRATEGY: We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (which contains the Cochrane Eyes and Vision Group Trials Register) on The Cochrane Library (Issue 3, 2005), MEDLINE (1966 to August 2005), EMBASE (1980 to 2005 wk 31), NRR 2005 Issue 3, LILACS (September 2004) and the reference lists of other reviews and book chapters on TON. We also contacted researchers in the field. There were no date or language restrictions in the electronic searches for trials. SELECTION CRITERIA: We planned to include only randomised controlled trials of TON in which any form of surgical intervention either on its own or in combination with steroids was compared to steroids alone or no treatment. DATA COLLECTION AND ANALYSIS: Two authors independently assessed the titles and abstracts identified from the search strategy. No studies were found that met our inclusion criteria and therefore none were included for analysis. MAIN
RESULTS: No studies were found that met our inclusion criteria. AUTHORS'
CONCLUSIONS: The current body of evidence consists mostly of small, retrospective case series. Given the wide range of surgical interventions used in TON it is very difficult to compare these studies, even qualitatively. However, there is a relatively high rate of spontaneous visual recovery and no evidence that surgical decompression of the optic nerve provides any additional benefit. On the other hand surgery carries a definite risk of complications such as postoperative cerebrospinal fluid leak and meningitis. The decision to proceed with surgery in TON therefore remains controversial and each case needs to be assessed on its own merits. Although there is an urgent need for an adequately powered, randomised controlled trial of surgical intervention in TON, this will prove a difficult endeavour.

Entities:  

Mesh:

Year:  2005        PMID: 16235388     DOI: 10.1002/14651858.CD005024.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  22 in total

1.  Erythropoietin: a novel treatment for traumatic optic neuropathy-a pilot study.

Authors:  Mohsen Bahmani Kashkouli; Farzad Pakdel; Mostafa Soltan Sanjari; Anousheh Haghighi; Marzieh Nojomi; Mohammad Hossein Homaee; Abtin Heirati
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-10-02       Impact factor: 3.117

2.  [Posttraumatic amaurosis after complex frontobasal fracture. Differential diagnosis and therapy].

Authors:  P U Lohnstein; J Schipper; A Berlis; N-C Gellrich; W Maier
Journal:  HNO       Date:  2007-11       Impact factor: 1.284

3.  Traumatic Optic Neuropathy-The Many Presentations and Treatment Options.

Authors:  Celia Chen
Journal:  Neuroophthalmology       Date:  2014-05-14

4.  Optic Canal Decompression and Direct Ophthalmic Artery Fibrinolysis for Traumatic Optic Neuropathy With Central Retinal Artery Occlusion.

Authors:  Krishna Vaitheeswaran; Preetinder Kaur; Shalini Garg; Monika Nadar
Journal:  Neuroophthalmology       Date:  2014-02-25

5.  [Traumatic optic nerve neuropathy. Longterm results following microsurgical optic nerve decompression].

Authors:  H-J Welkoborsky; H Möbius; L Bauer; B Wiechens
Journal:  HNO       Date:  2011-10       Impact factor: 1.284

Review 6.  Post-traumatic visual loss.

Authors:  Edward J Atkins; Nancy J Newman; Valérie Biousse
Journal:  Rev Neurol Dis       Date:  2008

7.  Mitochondrial targeted therapy with elamipretide (MTP-131) as an adjunct to tumor necrosis factor inhibition for traumatic optic neuropathy in the acute setting.

Authors:  Brian C Tse; Galina Dvoriantchikova; Wensi Tao; Ryan A Gallo; John Y Lee; Dmitry Ivanov; David T Tse; Daniel Pelaez
Journal:  Exp Eye Res       Date:  2020-08-03       Impact factor: 3.467

Review 8.  Controversies in ocular trauma classification and management: review.

Authors:  Rupesh Agrawal; Mehul Shah; Kamiar Mireskandari; Goh Kong Yong
Journal:  Int Ophthalmol       Date:  2013-01-22       Impact factor: 2.031

Review 9.  Trauma of the midface.

Authors:  Thomas S Kühnel; Torsten E Reichert
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2015-12-22

Review 10.  Traumatic Optic Neuropathy.

Authors:  Sun Young Jang
Journal:  Korean J Neurotrauma       Date:  2018-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.